Autoantibody profiling reveals that most SLE patients can be segregated into one of two autoantibody clusters: those with Ro52, Ro60, and La as targets, or those who are enriched for Sm-D3, U1-70k, and RNP-A autoantibodies (9). This evidence concerns the gene TRIM21 and systemic lupus erythematosus.